The human AMPKγ3 R225W mutation negatively impacts site‐1 nucleotide binding and does not enhance basal AMPKγ3‐associated activity nor glycogen production in human or mouse skeletal muscle.

MLA

Eskesen, Nicolas O., et al. “The Human AMPKγ3 R225W Mutation Negatively Impacts Site‐1 Nucleotide Binding and Does Not Enhance Basal AMPKγ3‐associated Activity nor Glycogen Production in Human or Mouse Skeletal Muscle.” Acta Physiologica, vol. 240, no. 10, Oct. 2024, pp. 1–19. EBSCOhost, https://doi.org/10.1111/apha.14213.

APA

Eskesen, N. O., Kjøbsted, R., Birk, J. B., Henriksen, N. S., Andersen, N. R., Ringholm, S., Pilegaard, H., & Wojtaszewski, J. F. P. (2024). The human AMPKγ3 R225W mutation negatively impacts site‐1 nucleotide binding and does not enhance basal AMPKγ3‐associated activity nor glycogen production in human or mouse skeletal muscle. Acta Physiologica, 240(10), 1–19. https://doi.org/10.1111/apha.14213

Chicago

Eskesen, Nicolas O., Rasmus Kjøbsted, Jesper Bratz Birk, Nicolai S. Henriksen, Nicoline R. Andersen, Stine Ringholm, Henriette Pilegaard, and Jørgen F. P. Wojtaszewski. 2024. “The Human AMPKγ3 R225W Mutation Negatively Impacts Site‐1 Nucleotide Binding and Does Not Enhance Basal AMPKγ3‐associated Activity nor Glycogen Production in Human or Mouse Skeletal Muscle.” Acta Physiologica 240 (10): 1–19. doi:10.1111/apha.14213.